BlackRock Group’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
WP
SGA
JSP
BlackRock Group's CLB Position: Q4 2016 in Review
BlackRock Group increased its Core Laboratories (CLB) stake by 6.5% in Q4 2016, buying an estimated $2.03M and bringing the position to 302,724 shares worth $36.3M. The position accounts for 0.02% of the portfolio, ranked #662.
BlackRock Group first reported a position in CLB in Q2 2013 and has held it in 15 quarters since. The position peaked at $51.7M in Q1 2014. 372 funds tracked by Wall St. Rank hold CLB as of Q4 2016.
- BlackRock Group held 302,724 shares of Core Laboratories worth $36.3M as of Q4 2016.
- BlackRock Group bought 18,356 Core Laboratories shares in Q4 2016, an estimated $2.03M.
- Core Laboratories made up 0.02% of BlackRock Group's portfolio in Q4 2016, its #662 holding.
- BlackRock Group first reported a position in Core Laboratories in Q2 2013 and has held it in 15 quarters since.
- BlackRock Group's Core Laboratories position peaked at $51.7M in Q1 2014.
- 372 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2016.
Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.